D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
RLMD holding history
Relmada Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RLMD overviewAll 13F holders of RLMDFull Q2 2026 holdings
- Shares (Q2 2026)
- 109,474
- Value
- $757.6K
- % of portfolio
- <0.1%
- Quarters held
- 8
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 109,474 | $757.6K | <0.1% | +109,474 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −10,649−100.0% | Sold out | Holders |
| Q4 2023 | 10,649 | $44.1K | <0.1% | −8,829−45.3% | Reduced | Holders |
| Q3 2023 | 19,478 | $58.4K | <0.1% | −23,239−54.4% | Reduced | Holders |
| Q2 2023 | 42,717 | $105.1K | <0.1% | −1,245−2.8% | Reduced | Holders |
| Q1 2023 | 43,962 | $99.4K | <0.1% | +28,290+180.5% | Added | Holders |
| Q4 2022 | 15,672 | $54.7K | <0.1% | −62,534−80.0% | Reduced | Holders |
| Q3 2022 | 78,206 | $2.90M | <0.1% | +78,206 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −10,487−100.0% | Sold out | Holders |
| Q1 2022 | 10,487 | $283.0K | <0.1% | +10,487 | New | Holders |